Patents by Inventor Birgitte Lund

Birgitte Lund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9061981
    Abstract: Disclosed herein are novel di-aromatic compounds of the general formula (I). Also pharmaceutical compositions comprising the novel compounds and the use of the novel compounds in treatment and prevention of diseases and disorders related to estrogen receptors are disclosed. Furthermore, methods for treating and preventing diseases and disorders related to estrogen receptors by administration of the novel compounds are disclosed.
    Type: Grant
    Filed: August 1, 2012
    Date of Patent: June 23, 2015
    Assignee: Acadia Pharmaceuticals Inc.
    Inventors: Roger Olsson, Birgitte Lund, Magnus Gustafsson
  • Publication number: 20140275284
    Abstract: Disclosed herein are novel di-aromatic compounds of the general formula (I). Also pharmaceutical compositions comprising the novel compounds and the use of the novel compounds in treatment and prevention of diseases and disorders related to estrogen receptors are disclosed. Furthermore, methods for treating and preventing diseases and disorders related to estrogen receptors by administration of the novel compounds are disclosed.
    Type: Application
    Filed: August 1, 2012
    Publication date: September 18, 2014
    Applicant: ACADIA PHARMACEUTICALS INC.
    Inventors: Roger Olsson, Birgitte Lund, Magnus Gustafsson
  • Publication number: 20090176837
    Abstract: Disclosed herein are novel compounds with activity at RAR? 2 receptors. Further disclosed are the use of such compounds for treatment of or to alleviate symptoms of cancer, neurological disorders such as memory deficits and schizophrenia, neurodegenerative disorders such as Parkinson's and Alzheimer's diseases, inflammatory disorders such as psoriasis and rheumatoid arthritis, eye disorders and depression.
    Type: Application
    Filed: July 12, 2006
    Publication date: July 9, 2009
    Applicant: SONY CORPORATION
    Inventors: Roger Olsson, Fabrice Piu, Birgitte Lund
  • Publication number: 20080009489
    Abstract: Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
    Type: Application
    Filed: June 28, 2007
    Publication date: January 10, 2008
    Applicant: Acadian Pharmaceuticals, Inc.
    Inventors: Nathalie Schlienger, Jan Pawlas, Alma Fejzic, Roger Olsson, Birgitte Lund, Fabrizio Badalassi, Rasmus Lewinsky, Mikkel Thygesen
  • Publication number: 20070004679
    Abstract: Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
    Type: Application
    Filed: February 6, 2006
    Publication date: January 4, 2007
    Inventors: Nathalie Schlienger, Jan Pawlas, Alma Fejzic, Roger Olsson, Birgitte Lund, Fabrizio Badalassi, Rasmus Lewinsky, Mikkel Thygesen, Douglas Bonhaus
  • Publication number: 20060173037
    Abstract: Disclosed herein is a novel class of aminophenyl compounds having the structure: wherein R1 is cyano or nitro and ring A is a bi- or tricyclic bridged heterocycle and to their use as modulators of androgen receptor for the treatment or prevention of conditions relating thereto.
    Type: Application
    Filed: February 6, 2006
    Publication date: August 3, 2006
    Inventors: Nathalie Schlienger, Mikkel Thygesen, Jan Pawlas, Fabrizio Badalassi, Rasmus Lewinsky, Birgitte Lund, Roger Olsson
  • Publication number: 20060160845
    Abstract: Disclosed herein is a novel class of aminophenyl compounds having the structure: wherein R1 is cyano or nitro and ring A is a bi- or tricyclic bridged heterocycle and to their use as modulators of androgen receptor for the treatment or prevention of conditions relating thereto.
    Type: Application
    Filed: January 9, 2006
    Publication date: July 20, 2006
    Inventors: Nathalie Schlienger, Mikkel Thygesen, Jan Pawlas, Fabrizio Badalassi, Rasmus Lewinsky, Birgitte Lund, Roger Olsson
  • Publication number: 20060014739
    Abstract: Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
    Type: Application
    Filed: May 16, 2005
    Publication date: January 19, 2006
    Inventors: Nathalie Schlienger, Jan Pawlas, Alma Fejzic, Roger Olsson, Birgitte Lund, Fabrizio Badalassi, Rasmus Lewinsky, Mikkel Thygesen